Top news of the week: 17.05.2022.
Startups
Massachusetts to compete for new federal "high risk-high reward" biomedical research agency
Today, a new effort was launched to rally support for locating the newly-funded federal Advanced Research Projects Agency for Health (ARPA-H)in Massachusetts.
US Pharma and Biotech Summit
The US Pharma and Biotech Summit returns to New York on May 11, 2022. Industry leaders and FT journalists will discuss regional and global trends in areas such as drug discovery, clinical ...
When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
The last time there was a big wave of biotech acquisitions, buyers snapped up early-stage companies much more often than they did during other periods, according to a new STAT analysis.
Quebec’s Life Sciences Strategy 2022-2025: A Promising Plan for BIOQuébec’s Members and Quebec’s Life Sciences Industry
BIOQuébec welcomes the tabling of the 2022-2025 Quebec Life Sciences Strategy (QLSS) which will support - and above all, foster - the growth of Quebec
Startups will likely lean toward M&A, not IPO
Today we discuss the prospect of a wave of startup acquisitions, a likely new diabetes blockbuster, and how lawmakers want to finally rein in the wild west world of cosmetics, …
The Current State of Partnering
The Massachusetts biotech cluster is largely made up of small and emerging companies that are making big bets on risky, cutting-edge science. Much of this innovation comes out of academia ...
A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’
Curie Bio, a new biotech investment firm from Zach Weinberg and Alexis Borisy is intended to, as they put it, “free the founders.”
Here are the 10 biotech companies at the highest risk of bankruptcy as the bear market worsens
Biotech stocks have lost nearly half their value this year, putting cash-starved or debt-laden firms at risk.